Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001839591-21-000001
Filing Date
2021-01-11
Accepted
2021-01-11 11:17:35
Documents
1
Effectiveness Date
2021-01-11
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 6917
  Complete submission text file 0001839591-21-000001.txt   7991
Mailing Address %GENE BY GENE LTD. 1445 NORTH LOOP W STE 820 HOUSTON TX 77008
Business Address %GENE BY GENE LTD. 1445 NORTH LOOP W STE 820 HOUSTON TX 77008 61412448486
MYDNA, INC (Filer) CIK: 0001839591 (see all company filings)

EIN.: 854330284 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-385814 | Film No.: 21519856